Injective’s Derivatives Dominate: Daily Volume Soars Past DEX Performance

Injective has achieved a notable milestone, surpassing $96.8 million in daily perpetual volume, demonstrating its commitment to derivatives-first growth. This performance outshines its traditional liquidity metrics, with TVL only reaching $26.3 million, highlighting Injective’s strategic focus on functionality over bloated reserves. 📈 💰 This shift is supported by the protocol’s surging activity in derivatives markets, as traders actively engage with the platform’s robust offering.